Stay informed with the latest updates for the inheritable blood disorders community.

Medical
vials
Novo Nordisk Experiencing Shortage of Rebinyn 3,000 IU Vials
NBDF & Community
National Bleeding Disorders Foundation Names Phil Gattone, M.Ed., Next Chief Executive Officer
National Bleeding Disorders Foundation Names Phil Gattone…
NBDF & Community
Black History Month - Being the Inspiration
Peer-Reviewed Journal Summaries
Study Suggests Hemophilia Patients' Preferences Evolving Along…
Industry
uniQure Announces Findings from HCC Case Investigation in HOPE-B Trial for Gene Therapy
Takeda's Voluntary Withdrawal: Alert on Misprinted Labels for VONVENDI®
Medical
Ampoule bottles on an assembly line
Patient Receives First Hemophilia A Gene Therapy Outside a Clinical Trial…
NBDF & Community
Blood Plasma Bag, IV Drip, Bag, Platelet, Blood Donation
NBDF and HFA Address Concerns on WHO's Recommendation of Cryoprecipitate…
Advocacy & Legislative
Capital Building
Government Relations Update - December 2023
Peer-Reviewed Journal Summaries
Physical Therapy
Pilot Study Explores Educational Needs of HTC Physical Therapists
Medical
Von Willebrand Disease test vial
Yale Researchers Explore the Possibilities of von Willebrand Factor
Industry
FDA Accepts Biologics License Application for Marstacimab
NBDF & Community
Analytics and Data Presentation
NBDF and ATHN Collaboration
Industry
CSL Presents Three Year Treatment Data for Hemophilia B Gene Therapy
Medical
Sickle Cell
FDA Approves Pair of Cell-Based Gene Therapies for Sickle Cell Disease
Interview with 2023 NYLI Cohort Member Paxton Mills